• 1
    Durai R,Yang SY,Sales KM,Seifalian AM,Goldspink G,Winslet MC. Insulin-like growth factor binding protein-4 gene therapy increases apoptosis by altering Bcl-2 and Bax proteins and decreases angiogenesis in colorectal cancer. Int J Oncol 2007; 30: 8838.
  • 2
    Firth SM,Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002; 23: 82454.
  • 3
    Hoeflich A,Reisinger R,Lahm H,Kiess W,Blum WF,Kolb HJ,Weber MM,Wolf E. Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter? Cancer Res 2001; 61: 860110.
  • 4
    Renehan AG,Jones J,Potten CS,Shalet SM,O'Dwyer ST. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer. Br J Cancer 2000; 83: 134450.
  • 5
    Jenab M,Riboli E,Cleveland RJ,Norat T,Rinaldi S,Nieters A,Biessy C,Tjonneland A,Olsen A,Overvad K,Gronbaek H,Clavel-Chapelon F, et al. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition. Int J Cancer 2007; 121: 36876.
  • 6
    Kaaks R,Toniolo P,Akhmedkhanov A,Lukanova A,Biessy C,Dechaud H,Rinaldi S,Zeleniuch-Jacquotte A,Shore RE,Riboli E. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000; 92: 1592600.
  • 7
    Hoeflich A,Wu M,Mohan S,Foll J,Wanke R,Froehlich T,Arnold GJ,Lahm H,Kolb HJ,Wolf E. Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology 1999; 140: 548896.
  • 8
    Diehl D,Oesterle D,Elmlinger MW,Hoeflich A,Wolf E,Lahm H. IGF-II transgenic mice display increased aberrant colon crypt multiplicity and tumor volume after 1,2-dimethylhydrazine treatment. JCarcinog 2006; 5: 24.
  • 9
    Cheng L,Lai MD. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol 2003; 9: 26429.
  • 10
    Yamada Y,Yoshimi N,Hirose Y,Matsunaga K,Katayama M,Sakata K,Shimizu M,Kuno T,Mori H. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res 2001; 61: 18748.
  • 11
    Papanikolaou A,Wang QS,Papanikolaou D,Whiteley HE,Rosenberg DW. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis. Carcinogenesis 2000; 21: 156772.
  • 12
    Lukanova A,Lundin E,Micheli A,Akhmedkhanov A,Rinaldi S,Muti P,Lenner P,Biessy C,Krogh V,Riboli E,Hallmans G,Berrino F, et al. Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy). Cancer Causes Control 2003; 14: 28592.
  • 13
    Cust AE,Allen NE,Rinaldi S,Dossus L,Friedenreich C,Olsen A,Tjonneland A,Overvad K,Clavel-Chapelon F,Boutron-Ruault MC,Linseisen J,Chang-Claude J, et al. Serum levels of C-peptide. IGFBP-1 and IGFBP-2 and endometrial cancer risk: results from the European prospective investigation into cancer and nutrition. Int J Cancer 2007; 120: 265664.
  • 14
    Palermo C,Manduca P,Gazzerro E,Foppiani L,Segat D,Barreca A. Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblasts. Am J Physiol Endocrinol Metab 2004; 286: E64857.
  • 15
    Hoeflich A,Fettscher O,Lahm H,Blum WF,Kolb HJ,Engelhardt D,Wolf E,Weber MM. Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells. Cancer Res 2000; 60: 8348.
  • 16
    Raju J,Bird RP. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. Cancer Res 2003; 63: 6595601.
  • 17
    Gunter MJ,Leitzmann MF. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem 2006; 17: 14556.
  • 18
    Pischon T,Lahmann PH,Boeing H,Friedenreich C,Norat T,Tjonneland A,Halkjaer J,Overvad K,Clavel-Chapelon F,Boutron-Ruault MC,Guernec G,Bergmann MM, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006; 98: 92031.
  • 19
    Lundqvist E,Kaprio J,Verkasalo PK,Pukkala E,Koskenvuo M,Soderberg KC,Feychting M. Co-twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins. Int J Cancer 2007; 121: 8108.
  • 20
    Ealey KN,Xuan W,Lu S,Archer MC. Colon carcinogenesis in liver-specific IGF-I-deficient (LID) mice. Int J Cancer 2008; 122: 4726.
  • 21
    Tripkovic I,Tripkovic A,Strnad M,Capkun V,Zekan L. Role of insulin-like growth factor-1 in colon cancerogenesis: a case-control study. Arch Med Res 2007; 38: 51925.
  • 22
    Renehan AG,O'Connell J,O'Halloran D,Shanahan F,Potten CS,O'Dwyer ST,Shalet SM. Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications. Horm Metab Res 2003; 35(11–12): 71225.
  • 23
    Mathews LS,Hammer RE,Brinster RL,Palmiter RD. Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology 1988; 123: 4337.
  • 24
    Paulsen JE,Loberg EM,Olstorn HB,Knutsen H,Steffensen IL,Alexander J. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat. Cancer Res 2005; 65: 1219.